Navin Goyal is a seasoned professional in clinical pharmacology and pharmacometrics with extensive experience at leading organizations. Currently serving as Executive Director at Johnson & Johnson since October 2024, Navin previously held the position of Senior Director and Group Lead at The Janssen Pharmaceutical Companies of Johnson & Johnson from June 2021 to October 2024. Navin's earlier roles include Director of Clinical Pharmacology, Modeling and Simulation at GSK from November 2014 to June 2021, and adjunct faculty in the College of Pharmacy at the University of Florida from February 2014 to 2009. Additionally, Navin completed internships at the Food and Drug Administration and GlaxoSmithKline focusing on population modeling. Navin earned a Ph.D. in Pharmaceutics from the University of Florida, completing the program in 2009.
This person is not in the org chart
This person is not in any teams
This person is not in any offices